The weekend report about a potential megamerger of AstraZeneca and Bristol Myers Squibb is raising a number of questions for both companies, according to biopharma analysts.
August 3, 2026 03:20 PM EDT
AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers
The weekend report about a potential megamerger of AstraZeneca and Bristol Myers Squibb is raising a number of questions for both companies …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
AstraZeneca Stock Nosedives On Mega-Merger Rumor
AstraZeneca said to have explored Bristol Myers merger | Fortune
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources
$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
AstraZeneca ‘in talks to create £300bn pharmaceutical giant’
Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
